nach oben

International Urogynecology Journal

Erschienen in:

01.06.2007 | Current Opinion/Update

Urogynaecological research: current and future developments

verfasst von: Gunnar Lose

Erschienen in: International Urogynecology Journal | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

The massive introduction of new products from device and drug industries together with a scanty device approval process and a growing scepticism about the reliability of drug trials call for new improved strategies in urogynaecological research. Device companies and physicians have a mutual ethical responsibility of contributing to create clinical data based on the framework of trials in surgery before new surgical products are implemented and disseminated. In respect of the patients’ altruism and confidence, which make drug trials possible, the industry and academia have an obligation to conduct and report clinical results in accordance with the highest standards of scientific and ethical integrity.

Abrams P, Cardozo L, Khoury S, Wein A (2005) Research methodology, vol 1, Chapter 3. 3rd International Consultation on Incontinence. Health Publication Ltd, Plymouth (Incontinence)

Walters MD (2003) The use and misuse of prosthetic materials in reconstructive pelvic surgery: does the evidence support our surgical practice? Int Urogynecol J 14:365–366CrossRef

Petri E, Kölbl H (2004) Eminence, or rather eloquence, or rather economy-based medicine? Int Urogynecol J 15:147–148CrossRef

McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D (2002) Randomised trials in surgery: problems and possible solution. BMJ 324:1448–1451PubMedCrossRef

Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215–1218PubMed

Lose G, Ostergard DR (1999) Medical technology assessment and surgery for stress incontinence. Int Urogynecol J 10:351–352CrossRef

Lilford R, Braunholtz D, Harris J, Gill T (2004) Trials in surgery. Br J Surg 91:6–16PubMedCrossRef

De Angelis C, Drazen JM, Frizelle FA et al (2004) Clinical trial registration: a statement from the international committee of medical journal editors. N Engl J Med 351:1250–1251PubMedCrossRef

Moynihan R (2003) Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement. BMJ 326:1189–1192PubMedCrossRef

10.

Korn D, Ehringhaus S (2006) Principles for strengthening the integrity of clinical research. PLOS Clin Trials 1(1):e1, May 2006PubMedCrossRef

11.

Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326:1167–1170PubMedCrossRef

12.

Gøtzsche PC (2005) Uafhængig klinisk interventionsforskning er meget påkrævet. Ugeskr Læger 167:1491–1494PubMed

13.

Herbison P, Hay-Smith J, Ellis K, Moor K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 326:841–844PubMedCrossRef

14.

Landis JR, Koplan S, Swift S, Versi E (2004) Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. J Urol 171:752–756PubMedCrossRef

15.

Hilton P (2007) Of porcupines and poodles—a joint challenge to industry and the profession. Int Urogynecol J 18(1):3–11CrossRef

16.

Dietz HP (2007) Bias in research and conflict of interest: why should we care? Int Urogynecol J Pelvic Floor Dysfunct 18(3):241–243. DOI 10.1007/s00192-006-0236-1 PubMedCrossRef

17.

Fontanarosa PB, Flanagin A, DeAngelis CD (2005) Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 294:110–111PubMedCrossRef

18.

Ehringhaus S, Korn D (2006) Principles for protecting integrity in the conduct and reporting of clinical trials. AAMC, 1–7 http://www.aamc.org/research/clinicaltrialsreporting//clinicaltrialsreporting.pdf March 2006

19.

Martinson BC, Anderson MS, de Vries R (2005) Scientists behaving badly. Nature 435(9):737–738PubMedCrossRef

Titel: Urogynaecological research: current and future developments
verfasst von: Gunnar Lose
Publikationsdatum: 01.06.2007
Verlag: Springer-Verlag
Erschienen in: International Urogynecology Journal / Ausgabe 6/2007
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-007-0318-8

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Urogynaecological research: current and future developments

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2007

The impact of pregnancy and childbirth in the urethra of female rats

Does bladder neck descent increase with age?

Laparoscopic intraperitoneal repair of high-up urinary bladder fistula: a review of 12 cases

Pyometra and recurrent prolapse after Le Fort colpocleisis

Vaginal wind—a treatment option

Biomechanical properties of prolapsed vaginal tissue in pre- and postmenopausal women

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie